-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's Intraday Session
Share
Listen to the news

Gainers

  • Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 63.0% to $0.74 during Friday's regular session. The market value of their outstanding shares is at $1.6 million.
  • OneMedNet (NASDAQ:ONMD) shares rose 38.48% to $1.23. The company's market cap stands at $46.3 million.
  • Organon (NYSE:OGN) shares moved upwards by 28.66% to $11.06. The company's market cap stands at $2.2 billion.
  • Enveric Biosciences (NASDAQ:ENVB) shares increased by 27.53% to $5.13. The company's market cap stands at $7.9 million.
  • iTonic Holdings (NASDAQ:ITOC) shares increased by 19.75% to $0.36. The company's market cap stands at $5.1 million.
  • Alpha Compute (NASDAQ:ALP) shares moved upwards by 15.79% to $0.21. The market value of their outstanding shares is at $4.2 million.

Losers

  • Sonoma Pharmaceuticals (NASDAQ:SNOA) stock declined by 40.0% to $1.08 during Friday's regular session. The company's market cap stands at $3.1 million.
  • iSpecimen (NASDAQ:ISPC) stock declined by 20.91% to $0.13. The market value of their outstanding shares is at $4.8 million.
  • Citius Pharmaceuticals (NASDAQ:CTXR) stock decreased by 20.48% to $0.74. The market value of their outstanding shares is at $20.8 million.
  • NextCure (NASDAQ:NXTC) stock fell 19.68% to $9.96. The company's market cap stands at $43.4 million.
  • Advanced Biomed (NASDAQ:ADVB) shares fell 15.62% to $5.46. The company's market cap stands at $8.8 million.
  • Silexion Therapeutics (NASDAQ:SLXN) stock fell 13.06% to $0.8. The company's market cap stands at $3.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending